Biology company completed C1 round of financing and started C2 round of financing.

On July 9th, Zhejiang Shuwen Biotechnology Co., Ltd. announced that it has recently completed nearly 100 million yuan in Series C1 financing and has begun Series C2 financing. This round of financing was led by Jin Chuang Tu, with continued investment from existing shareholder Yuan Sheng Chuang Tu. The financing funds will be used to accelerate the domestic and international market promotion of Shuwen Biotechnology's globally pioneering diagnostic products, as well as to increase investment in new product research and development, further enrich and improve the company's pipeline of precision diagnosis and treatment products for women's health.